Speciality healthcare solutions company.
Issues relating to incentives for life sciences research.
H.R. 523/S. 232 - Protect Medical Innovation Act of 2013. Oversight of implementation of the America Invents Act.
Issues relating to patent settlements, including S. 214: Preserve Access to Affordable Generics Act.
H.R. 3309: Innovation Act.
S. 1720: Patent Transparency and Improvements Act of 2013. Issues relating to bioequivalence and related administrative procedures.
Issues relating to prescription drug abuse.
Issues relating to incentives for tamper-resistant formulations.
H.R. 486: Stop Tampering of Prescription Pills Act of 2013.Issues relating to Medicare Part D rebates.
Issues relating to health information technology.
H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013.
Compounding and drug supply chain legislation.
H.R. 3204: Drug Quality and Security Act.
Issues relating to products containing high doses of acetaminophen.
Issues relating to the labeling of generic drugs.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE GIBSON GROUP, LLC
601 Thirteenth Street, N.W., Suite B2 North, Washington, DC, 20005, US
JOSEPH H GIBSON JOSEPH H GIBSON JOSEPH H GIBSON (Counsel, House Judiciary Comm. '95-'97)
Counsel, House Judiciary Comm. '95-'97